Bandingkan Harga & Kinerja Hetzer Medical Indonesia Tbk. (MEDS) vs Trimegah Karya Pratama Tbk. (UVCR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Hetzer Medical Indonesia Tbk. dan Trimegah Karya Pratama Tbk.: Hetzer Medical Indonesia Tbk. diperdagangkan di Rp73 (kapitalisasi pasar 109,38 M, volume 24 jam 60,43 jt), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 292,02 M, volume 24 jam 23,22 jt). Perbedaan utamanya: Trimegah Karya Pratama Tbk. jauh lebih besar — sekitar 2,7× kapitalisasi pasar Hetzer Medical Indonesia Tbk., dan Hetzer Medical Indonesia Tbk. lebih aktif diperdagangkan (60,43 jt vs 23,22 jt). Mana yang lebih baik tergantung tujuan investasimu.
| MEDS | UVCR | |
|---|---|---|
Kapitalisasi Pasar | 109,38 M | 292,02 M |
Volume | 60,43 jt | 23,22 jt |
Lot | 604,35 rb | 232,24 rb |
Perputaran | 4,46 M | 3,36 M |
Harga Rata-rata | 73,8 | 144,89 |
Nilai Transaksi | 4,46 M | 3,36 M |
Harga Ekuilibrium Indikatif | 73 | 146 |
Volume Ekuilibrium Indikatif | 12,68 rb | 410 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Selengkapnya di halaman MEDS →Tentang Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Selengkapnya di halaman UVCR →
